- Current report filing (8-K)
November 16 2012 - 4:06PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November
16, 2012
MAKO Surgical
corp.
(Exact name of registrant as specified in its charter)
Delaware
|
001-33966
|
20-1901148
|
(State or other jurisdiction of
incorporation)
|
(Commission File
Number)
|
(IRS Employer
Identification No.)
|
255 Davie Road Fort Lauderdale, Florida 33317
(Address of principal executive offices, including zip
code)
(954) 927-2044
(Registrant’s telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01
.
|
Other Events
.
|
The Company is filing certain exhibits as part of
this Current Report on Form 8-K in connection with its filing with the Securities and Exchange Commission of a final prospectus
supplement, dated September 14, 2012, and a prospectus, dated May 9, 2012, related to the offering of the Company’s common
stock, par value $0.001 per share (the “Offering Shares”). The Prospectus Supplement forms a part of, and the sale
of Offering Shares is registered under, the Company’s Registration Statement on Form S-3 (Registration No. 333-181277).
See “Item 9.01. Financial Statements and Exhibits.”
Item 9.01
.
|
Financial Statements and Exhibits
.
|
|
|
|
(a)
|
Not applicable.
|
|
|
|
|
(b)
|
Not applicable.
|
|
|
|
|
(c)
|
Not applicable.
|
|
|
|
|
(d)
|
Exhibits
. The following exhibits are being filed herewith:
|
|
|
|
|
|
(5.1)
|
Opinion of Foley & Lardner LLP, dated November 16, 2012.
|
|
|
|
|
|
|
(23.1)
|
Consent of Foley & Lardner LLP (contained in Exhibit (5.1) hereto).
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
MAKO SURGICAL CORP.
|
|
|
|
|
|
|
Date: November 16, 2012
|
By:
|
/s/ Menashe R. Frank
|
|
|
Menashe R. Frank
Senior Vice President,
General Counsel and Secretary
|
MAKO SURGICAL CORP.
Exhibit
Index to Current Report on Form 8-K
Dated
November 16
, 2012
Exhibit
Number
|
|
|
|
(5.1)
|
Opinion of Foley & Lardner LLP, dated November 16, 2012.
|
|
|
(23.1)
|
Consent of Foley & Lardner LLP (contained in Exhibit (5.1) hereto).
|
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024